Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RFL |
---|---|---|
09:32 ET | 3281 | 1.92 |
09:33 ET | 200 | 1.92 |
09:42 ET | 159 | 1.92 |
09:57 ET | 362 | 1.92 |
10:09 ET | 740 | 1.9258 |
10:18 ET | 2200 | 1.91 |
10:33 ET | 110 | 1.91 |
10:36 ET | 342 | 1.9 |
10:40 ET | 100 | 1.9 |
10:44 ET | 526 | 1.89 |
10:54 ET | 145 | 1.91 |
11:00 ET | 3002 | 1.91 |
11:05 ET | 1500 | 1.9241 |
11:30 ET | 292 | 1.95 |
11:32 ET | 332 | 1.95 |
11:54 ET | 300 | 1.98 |
11:56 ET | 200 | 2.0077 |
12:14 ET | 500 | 1.97 |
12:33 ET | 500 | 1.9794 |
12:57 ET | 201 | 1.97 |
01:09 ET | 300 | 1.98 |
01:20 ET | 2500 | 1.965 |
01:31 ET | 250 | 1.95 |
01:44 ET | 202 | 1.975 |
02:36 ET | 400 | 1.945 |
02:57 ET | 222 | 1.93 |
02:59 ET | 1059 | 1.93 |
03:03 ET | 500 | 1.9389 |
03:08 ET | 100 | 1.96 |
03:12 ET | 200 | 1.95 |
04:00 ET | 4007 | 1.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Rafael Holdings Inc | 47.1M | -1.3x | --- |
Envoy Medical Inc | 44.1M | -1.7x | --- |
Nexalin Technology Inc | 49.1M | -6.1x | --- |
Harvard Apparatus Regenerative Technology Inc | 44.6M | -5.2x | --- |
Vivos Inc | 35.5M | -12.2x | --- |
BioSig Technologies Inc | 34.5M | -1.3x | --- |
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). It holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). It holds a portion of a commercial building in Israel.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.1M |
---|---|
Revenue (TTM) | $637.0K |
Shares Outstanding | 24.7M |
Rafael Holdings Inc does not pay a dividend. | |
Beta | 1.08 |
EPS | $-1.45 |
Book Value | $3.34 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 74.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,367.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.